First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure

J Heart Lung Transplant. 2005 Aug;24(8):1150-4. doi: 10.1016/j.healun.2005.01.014.

Abstract

The VentrAssist device left ventricular assist system, designed for permanent implantation, is a novel centrifugal pump with a hydrodynamically suspended rotor. The first human implant was into a 72-year-old man with New York Heart Association (NYHA) class IV heart failure due to idiopathic dilated cardiomyopathy. The implant and recovery were uneventful, and the patient survives at 17 months, is NYHA class II, and lives at home. This device shows promise in end-stage heart failure for permanent implantation and bridge to transplantation.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cardiomyopathy, Dilated / diagnosis
  • Cardiomyopathy, Dilated / surgery*
  • Equipment Design
  • Equipment Safety
  • Follow-Up Studies
  • Heart Failure / diagnosis
  • Heart Failure / surgery*
  • Heart Ventricles / pathology
  • Heart Ventricles / surgery
  • Heart-Assist Devices*
  • Humans
  • Male
  • Risk Assessment
  • Severity of Illness Index
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / surgery*